FDA Investigator Rafael Nevarez
Rafael Nevarez has inspections in 4 countries as of 24 Mar 2023. Rafael Nevarez has collaborated with a combined 836 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
9
Last Inspection Date:
24 Mar 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Italy,
United States of America,
Spain,
Germany
Co-Investigator(s):
Adalberto Cajigas,
Alicia M Mozzachio,
Ariel Cruz Figueroa,
Arlene M Badillo,
Carlos A Medina,
CDR Ileana Barreto Pettit,
Colleen F Hoyt,
Dr. Carmelo Rosa,
Edwin Martinez,
Frederick L Fricke,
Hector J Colon Torres,
Ileana Pettit,
Joe X Phillips,
Jorge L Guadalupe,
Jorge L Lajara,
Jose A Lopez,
Jose A Moreno,
Jose Acruz Gonzalez,
Jose E Melendez, DDC,
Jose Melendez,
Jose R Lopez,
Jose Velez,
Karl D Hezel,
Kent C Faul,
Laiza V Garcia,
Lance M De Souza, MBA,
Leonard H Lavi,
Luis A Dasta,
Marianela Aponte Cruz,
Maribel V Juarbe,
Marie T Falcone,
Marta E Gonzalez,
Mra Mcculloughj,
Myriam M Sosa,
Patrick C Klotzbuecher,
Penny H Mccarver,
Rafael E Cruz,
Rafael Nevarez Nieves,
Ramon A Hernandez,
Reba A Gates,
Rebeca M Melendez,
Rebecca Parrilla,
Rebecca Rodriguez,
Steven B Barber,
Vlada Matusovsky,
Yvonne C Mcknight,
Yvonne E Lozano
Rafael Nevarez's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2001 | EIR | Pfizer Pharmaceuticals LLC - EIR, 2001-12-14 |
June, 2000 | EIR | Industriale Chimica SRL - EIR, 2000-06-22 |
December, 2001 | FDA 483 | Pfizer Pharmaceuticals LLC - Form 483, 2001-12-14 |
June, 2002 | FDA 483 | Farmhispania S.A. - Form 483, 2002-06-07 |
November, 2000 | EIR | Patheon Puerto Rico, Inc. - EIR, 2000-11-08 |
May, 2000 | EIR | Knoll LLC - EIR, 2000-05-18 |
June, 2002 | FDA 483 | INKE S.A. - Form 483, 2002-06-12 |
June, 2002 | EIR | INKE S.A. - EIR, 2002-06-12 |
June, 2000 | EIR | BRACCO IMAGING SPA - EIR, 2000-06-16 |
July, 2004 | FDA 483 | Lohmann Therapie-Systeme AG - Form 483, 2004-07-28 |
September, 2001 | EIR | Knoll LLC - EIR, 2001-09-28 |
December, 2001 | FDA 483 Response | Pfizer Pharmaceuticals LLC - Form 483R, 2002-01-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more